Free database of papers and journals






Results 1 to 20 of 180 articles found
2020

[Communication] Hydroxychloroquine for COVID-19: Myths vs facts

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] A case of generalized granuloma annulare successfully treated by hydroxychloroquine

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Hydroxychloroquine-induced erythroderma: A rare adverse effect of a commonly used drug

Dermatologic Therapy (1.3 69), 33, .
2019

Hydroxychloroquine combined with superficial X-ray—A new therapeutic method in the treatment of morphea profunda

Dermatologic Therapy (1.3 69), 32, .
2020

[Communication] A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Lupus erythematosus tumidus in an adolescent with beta thalassemia minor successfully controlled with hydroxychloroquine

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic

Dermatologic Therapy (1.3 69), 33, .
2020

Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine

Dermatologic Therapy (1.3 69), 33, .
2020

Dendritic cells as predictive markers of responsiveness to hydroxychloroquine treatment in primary cicatricial alopecia patients

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Comment on “Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine”: Report of a COVID-19 patient with particular findings

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Refractory leg ulcers in prolidase deficiency with antiphospholipid antibody positivity responding to aspirin-hydroxychloroquine-vitamin C combination therapy

Dermatologic Therapy (1.3 69), 33, .
2018

Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine

Dermatologic Therapy (1.3 69), 31, e12660.
2020

[Communication] Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19

Dermatologic Therapy (1.3 69), 33, .
2007

New concepts in antimalarial use and mode of action in dermatology

Dermatologic Therapy (1.3 69), 20, 160-174.
2020

[Communication] Pustular psoriasis exacerbated by COVID-19 in a patient with the history of psoriasis

Dermatologic Therapy (1.3 69), 33, .
2021

[Communication] Generalized pustular psoriasis following COVID-19

Dermatologic Therapy (1.3 69), 34, .
2020

[Communication] Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak

Dermatologic Therapy (1.3 69), 33, .
2020

[Communication] Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties

Dermatologic Therapy (1.3 69), 33, .
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions